The biomaterial functions in such a way that it can be used to deliver bioactive agents to the source of infection known to be on the device surface, in a controlled way. In addition to offering controlled drug delivery the innovative biomaterial has been designed to include a safeguard mechanism that that will initiate during the early stages of infection. This mechanism involves the use of materials that will self cleanse once they have become infected with bacteria. This should enable urinary devices and ultimately patients to remain free from infection for the duration the device is to be used.

Value Proposition

The use of implanted medical devices is now routine in healthcare management within hospitals and nursing homes. Although there are substantial benefits associated with the use of inserted medical devices, there are very worryingly a number o f potentially dangerous complications that may lead to an increase in the time patients remain in hospital and more importantly in an increase in the number of patient deaths associated with the use of these devices. These complications arise principally because of the way in which a patient’s body reacts to insertion of a medical device and what it perceives to be as a foreign object. Consequently patients are often plagued by infection associated with the insertion of a medical device and this is seen to be one of the most critical disadvantages of an otherwise highly effective and beneficial medical treatment. Therefore there is an urgent need to improve what is often referred to as device-related infection through the development of new intelligent medical materials.

Quick Links

REF 2014 >>
Pure support >>
Support funds >>
Develop a Collaboration >>
Contact us >>